During the past decade, Wuhan Medical Treatment Center conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wuhan Medical Treatment Center" #1 sponsor was "Peking University First Hospital" with 3 trials, followed by "Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd." with 1 trials sponsored, "Beijing Chest Hospital" with 1 trials sponsored, "CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd." with 1 trials sponsored and "Ginkgopharma CO., LTD" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wuhan Medical Treatment Center" #1 collaborator was "Wuhan Institute for Tuberculosis Control" with 2 trials as a collaborator, "Wuhan Union Hospital, China" with 2 trials as a collaborator, "Anhui Chest Hospital" with 1 trials as a collaborator, "Beijing Children's Hospital" with 1 trials as a collaborator and "Beijing Research Institute for Tuberculosis Control" with 1 trials as a collaborator. Other collaborators include 26 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Wuhan Medical Treatment Center" are "COVID-19" (3 trials), "Bioequivalence" (1 trials), "Hepatitis C Virus Infection" (1 trials), "Tuberculosis Diagnosis" (1 trials) and "Tuberculosis, Pulmonary" (1 trials). Many other conditions were trialed in "Wuhan Medical Treatment Center" in a lesser frequency.

Most popular intervention types in "Wuhan Medical Treatment Center" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Favipiravir" (2 trials), "AmBisome®" (1 trials), "Amphotericin B liposome for injection" (1 trials), "Anluohuaxian" (1 trials) and "ESAT6-CFP10 in left arm and TB-PPD in right arm" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wuhan Medical Treatment Center" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Wuhan Medical Treatment Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Wuhan Medical Treatment Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Wuhan Medical Treatment Center, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".